BG43189A3 - Method for preparing of acetylic ester of erythromycine stearate - Google Patents
Method for preparing of acetylic ester of erythromycine stearateInfo
- Publication number
- BG43189A3 BG43189A3 BG068285A BG6828585A BG43189A3 BG 43189 A3 BG43189 A3 BG 43189A3 BG 068285 A BG068285 A BG 068285A BG 6828585 A BG6828585 A BG 6828585A BG 43189 A3 BG43189 A3 BG 43189A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- ester
- stearate
- compound
- erythromycin
- acetylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK5884A DK149776C (da) | 1984-01-06 | 1984-01-06 | Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG43189A3 true BG43189A3 (en) | 1988-04-15 |
Family
ID=8089251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG068285A BG43189A3 (en) | 1984-01-06 | 1985-01-05 | Method for preparing of acetylic ester of erythromycine stearate |
Country Status (38)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874614A (en) * | 1985-03-25 | 1989-10-17 | Abbott Laboratories | Pharmaceutical tableting method |
| US4863741A (en) * | 1985-03-25 | 1989-09-05 | Abbott Laboratories | Tablet composition for drug combinations |
| JP3382159B2 (ja) * | 1998-08-05 | 2003-03-04 | 株式会社東芝 | 情報記録媒体とその再生方法及び記録方法 |
| US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| US7399488B2 (en) * | 2002-07-05 | 2008-07-15 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| KR20060108692A (ko) * | 2003-10-31 | 2006-10-18 | 알자 코포레이션 | 메트포르민의 개선된 흡수를 위한 조성물 및 제형 |
| CA2916869A1 (en) | 2004-06-12 | 2005-12-29 | Jane C. Hirsh | Abuse-deterrent drug formulations |
| WO2006025882A2 (en) | 2004-08-25 | 2006-03-09 | The Uab Research Foundation | Absorption enhancers for drug administration |
| US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
| EP2158920A1 (en) | 2006-06-23 | 2010-03-03 | Aegis Therapeutics LLC | Stabilizing alkylglycoside compositions and methods thereof |
| US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| CN108892709A (zh) | 2011-05-18 | 2018-11-27 | 欧莫德里斯制药公司 | 改良的肽药物 |
| ES2906975T3 (es) | 2012-11-20 | 2022-04-21 | Eumederis Pharmaceuticals Inc | Productos farmacéuticos de péptidos mejorados |
| MX360816B (es) | 2012-11-20 | 2018-11-15 | Mederis Diabetes Llc | Productos farmacéuticos peptídicos mejorados para la resistencia a la insulina. |
| WO2014140699A1 (en) * | 2013-03-13 | 2014-09-18 | Calyx Chemicals And Pharmaceuticals Ltd | A novel process of liberation of erythromycin and preparation of its salts |
| PT3155017T (pt) | 2014-05-28 | 2024-05-14 | Mederis Diabetes Llc | Farmacêuticos peptídicos melhorados para resistência à insulina |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
| PH12019502594A1 (en) | 2017-05-19 | 2020-10-26 | Lunella Biotech Inc | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| WO2019108729A1 (en) | 2017-12-01 | 2019-06-06 | Lunella Biotech, Inc. | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| WO2019157099A1 (en) | 2018-02-06 | 2019-08-15 | Aegis Therapeutics, Llc | Intranasal epinephrine formulations and methods for the treatment of disease |
| GB2600026B (en) | 2018-02-06 | 2022-10-12 | Aegis Therapeutics Llc | Intranasal epinephrine formulations and methods for the treatment of disease |
| AU2019402099B2 (en) * | 2018-12-17 | 2025-01-23 | Lunella Biotech, Inc. | Triple combination therapies for anti-aging |
| AU2019403048B2 (en) * | 2018-12-17 | 2025-01-23 | Lunella Biotech, Inc. | Triple combination therapies for targeting mitochondria and killing cancer stem cells |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1011117B (de) * | 1953-11-16 | 1957-06-27 | Abbott Lab | Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen |
| FR1179208A (fr) * | 1953-11-16 | 1959-05-21 | Abbott Lab | Procédé de préparation de sels d'érythromycine |
| GB834397A (en) * | 1958-07-29 | 1960-05-04 | Lilly Co Eli | Therapeutic compositions comprising erythromycin esters |
| US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
| FR2473525A1 (fr) * | 1980-01-11 | 1981-07-17 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1984
- 1984-01-06 DK DK5884A patent/DK149776C/da not_active IP Right Cessation
- 1984-12-18 NZ NZ210606A patent/NZ210606A/en unknown
- 1984-12-20 IL IL73885A patent/IL73885A/xx not_active IP Right Cessation
- 1984-12-21 AU AU37059/84A patent/AU565688B2/en not_active Ceased
- 1984-12-21 GB GB08432368A patent/GB2152502B/en not_active Expired
- 1984-12-27 US US06/686,753 patent/US4599326A/en not_active Expired - Fee Related
- 1984-12-28 SE SE8406671A patent/SE461854B/sv not_active IP Right Cessation
- 1984-12-28 BE BE0/214265A patent/BE901411A/fr not_active IP Right Cessation
- 1984-12-28 PT PT79777A patent/PT79777B/pt not_active IP Right Cessation
- 1984-12-28 IS IS2968A patent/IS2968A7/is unknown
- 1984-12-28 ZA ZA8410143A patent/ZA8410143B/xx unknown
- 1984-12-31 NL NL8403979A patent/NL8403979A/nl not_active Application Discontinuation
-
1985
- 1985-01-02 NO NO850007A patent/NO160263C/no unknown
- 1985-01-02 MA MA20540A patent/MA20316A1/fr unknown
- 1985-01-02 FR FR8500005A patent/FR2557878B1/fr not_active Expired
- 1985-01-03 AT AT0000985A patent/AT386414B/de not_active IP Right Cessation
- 1985-01-03 FI FI850023A patent/FI77249C/fi not_active IP Right Cessation
- 1985-01-04 SU SU853836820A patent/SU1410866A3/ru active
- 1985-01-04 DE DE19853500179 patent/DE3500179A1/de active Granted
- 1985-01-04 KR KR1019850000008A patent/KR900006237B1/ko not_active Expired
- 1985-01-04 PL PL1985251457A patent/PL144349B1/pl unknown
- 1985-01-04 CH CH31/85A patent/CH666275A5/de not_active IP Right Cessation
- 1985-01-04 CA CA000471563A patent/CA1224461A/en not_active Expired
- 1985-01-04 HU HU8537A patent/HU196221B/hu not_active IP Right Cessation
- 1985-01-04 YU YU20/85A patent/YU44485B/xx unknown
- 1985-01-04 ES ES539349A patent/ES8605818A1/es not_active Expired
- 1985-01-04 CS CS8596A patent/CS247191B2/cs unknown
- 1985-01-04 LU LU85721A patent/LU85721A1/fr unknown
- 1985-01-04 IT IT19012/85A patent/IT1184304B/it active
- 1985-01-04 IE IE22/85A patent/IE57967B1/en not_active IP Right Cessation
- 1985-01-05 BG BG068285A patent/BG43189A3/xx unknown
- 1985-01-07 RO RO117230A patent/RO91262B/ro unknown
- 1985-01-07 PH PH31689A patent/PH22471A/en unknown
- 1985-01-07 MX MX203973A patent/MX156277A/es unknown
- 1985-01-07 JP JP60000744A patent/JPS60158197A/ja active Granted
-
1988
- 1988-10-28 KE KE3841A patent/KE3841A/xx unknown
-
1989
- 1989-07-21 CY CY1462A patent/CY1462A/en unknown
-
1990
- 1990-02-15 HK HK115/90A patent/HK11590A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG43189A3 (en) | Method for preparing of acetylic ester of erythromycine stearate | |
| DE3650265D1 (de) | Makrolide Antibiotika und Verfahren zu deren Herstellung. | |
| SE8406138L (sv) | Nya retinoider | |
| RU94042916A (ru) | 9a-n - (n'-карбамоил) - и 9a-n - (n'-тиокарбамоил) производные 9-деоксо- 9a - аза - 9a - гомоэтирмицина а, способ их получения и фармкомпозиция на их основе | |
| GB1247612A (en) | Lincomycin derivatives and the manufacture thereof | |
| SE7707689L (sv) | 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav | |
| SE7903200L (sv) | Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration | |
| NO872574L (no) | Fremgangsmte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
| ES418743A1 (es) | Un procedimiento para la preparacion del complejo antibio- tico de la butirosina. | |
| ES427433A1 (es) | Un procedimiento para preparar un compuesto quimico selec- cionado del grupo que consiste en o-tiocarbamato de nitroi- midazolil-etilo. | |
| SE7701834L (sv) | 4-hydroxi-2-kinolinon-3-karboxylsyraestrar | |
| SE8402361L (sv) | Nya acylaminofenolderivat | |
| SE8701019D0 (sv) | Makrolidforening | |
| JPS572298A (en) | Erythromycin derivative | |
| NO871187L (no) | Fremgangsmaate til fremstilling av en blanding inneholdende indometacin. | |
| GB1463038A (en) | Benzhydryloxyalkylamine derivatives and process for the preparation thereof | |
| GB1433977A (en) | Acyl derivatives | |
| JPS5432493A (en) | Preparation of macrolide antibiotics derivatives | |
| JPS57139015A (en) | Remedy for infectious disease for oral administration | |
| SE7707552L (sv) | Antibiotikum bl580delta | |
| KR890006643A (ko) | β-락탐 항생물질의 모노하이드레이트 및 용매화합물 | |
| SU667130A3 (ru) | Способ получени соли лизина и -метил-(изопропил-2-инданил-5) уксусной кислоты | |
| JPS57140717A (en) | Antidiabetic agent containing o- or m-aminobenzoic acid derivative | |
| GB1397697A (en) | Phenoxyalicyclic carboxylic acid derivatives methods of making them and compositions containing them | |
| GB1531055A (en) | Sulphonium salts of esters of substituted acetic acid |